|
1
|
Liu Z, Luo G, Guo M, Jin K, Xiao Z, Liu L,
Liu C, Xu J, Ni Q, Long J, et al: Lymph node status predicts the
benefit of adjuvant chemoradiotherapy for patients with resected
pancreatic cancer. Pancreatology. 15:253–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lim JE, Chien MW and Earle CC: Prognostic
factors following curative resection for pancreatic adenocarcinoma:
A population-based, linked database analysis of 396 patients. Ann
Surg. 237:74–85. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vaupel P and Mayer A: Hypoxia in cancer:
Significance and impact on clinical outcome. Cancer Metastasis Rev.
26:225–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bristow RG and Hill RP: Hypoxia and
metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev
Cancer. 8:180–192. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frank I, Blute ML, Cheville JC, Lohse CM,
Weaver AL and Zincke H: An outcome prediction model for patients
with clear cell renal cell carcinoma treated with radical
nephrectomy based on tumor stage, size, grade and necrosis: The
SSIGN score. J Urol. 168:2395–2400. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fisher ER, Palekar AS, Gregorio RM,
Redmond C and Fisher B: Pathological findings from the national
surgical adjuvant breast project (Protocol No. 4). IV. Significance
of tumor necrosis. Hum Pathol. 9:523–530. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Swinson DE, Jones JL, Richardson D, Cox G,
Edwards JG and O'Byrne KJ: Tumour necrosis is an independent
prognostic marker in non-small cell lung cancer: Correlation with
biological variables. Lung Cancer. 37:235–240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hiraoka N, Ino Y, Sekine S, Tsuda H,
Shimada K, Kosuge T, Zavada J, Yoshida M, Yamada K, Koyama T, et
al: Tumour necrosis is a postoperative prognostic marker for
pancreatic cancer patients with a high interobserver
reproducibility in histological evaluation. Br J Cancer.
103:1057–1065. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pearlman BL and Traub N: Sustained
virologic response to antiviral therapy for chronic hepatitis C
virus infection: A cure and so much more. Clin Infect Dis.
52:889–900. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Valent P, Orazi A, Büsche G, Schmitt-Gräff
A, George TI, Sotlar K, Streubel B, Beham-Schmid C, Cerny-Reiterer
S, Krieger O, et al: Standards and impact of hematopathology in
myelodysplastic syndromes (MDS). Oncotarget. 1:483–496. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kwon W, He J, Higuchi R, Son D, Lee SY,
Kim J, Kim H, Kim SW, Wolfgang CL, Cameron JL, et al: Multinational
validation of the American Joint Committee on Cancer 8th edition
pancreatic cancer staging system in a pancreas head cancer cohort.
J Hepatobiliary Pancreat Sci. 25:418–427. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu R, Wakabayashi G, Kim HJ, Choi GH,
Yiengpruksawan A, Fong Y, He J, Boggi U, Troisi RI, Efanov M, et
al: International consensus statement on robotic hepatectomy
surgery in 2018. World J Gastroenterol. 25:1432–1444. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chun YS, Cooper HS, Cohen SJ, Konski A,
Burtness B, Denlinger CS, Astsaturov I, Hall MJ and Hoffman JP:
Significance of pathologic response to preoperative therapy in
pancreatic cancer. Ann Surg Oncol. 18:3601–3607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tomita Y, Azuma K, Nonaka Y, Kamada Y,
Tomoeda M, Kishida M, Tanemura M and Miyoshi E: Pancreatic fatty
degeneration and fibrosis as predisposing factors for the
development of pancreatic ductal adenocarcinoma. Pancreas.
43:1032–1041. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vakkila J and Lotze MT: Inflammation and
necrosis promote tumour growth. Nat Rev Immunol. 4:641–648. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bachem MG, Schünemann M, Ramadani M, Siech
M, Beger H, Buck A, Zhou S, Schmid-Kotsas A and Adler G: Pancreatic
carcinoma cells induce fibrosis by stimulating proliferation and
matrix synthesis of stellate cells. Gastroenterology. 128:907–921.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial- mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vonlaufen A, Joshi S, Qu C, Phillips PA,
Xu Z, Parker NR, Toi CS, Pirola RC, Wilson JS, Goldstein D, et al:
Pancreatic stellate cells: Partners in crime with pancreatic cancer
cells. Cancer Res. 68:2085–2093. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jacoby C, Borg N, Heusch P, Sauter M,
Bönner F, Kandolf R, Klingel K, Schrader J and Flögel U:
Visualization of immune cell infiltration in experimental viral
myocarditis by (19)F MRI in vivo. MAGMA. 27:101–106. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Heeswijk RB, De Blois J, Kania G,
Gonzales C, Blyszczuk P, Stuber M, Eriksson U and Schwitter J:
Selective in vivo visualization of immune-cell infiltration in a
mouse model of autoimmune myocarditis by fluorine-19 cardiac
magnetic resonance. Circ Cardiovasc Imaging. 6:277–284. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Figueiredo S, Cutrin JC, Rizzitelli S, De
Luca E, Moreira JN, Geraldes CF, Aime S and Terreno E: MRI tracking
of macrophages labeled with glucan particles entrapping a water
insoluble paramagnetic Gd-based agent. Mol Imaging Biol.
15:307–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
